SWOG S1605: Moving Beyond Systemic Immune Checkpoint Inhibitor Monotherapy in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer

Saved in:
Bibliographic Details
Published in:European urology 2023-12, Vol.84 (6), p.545-546
Main Authors: Kulkarni, Girish S., Wettstein, Marian S.
Format: Article
Language:English
Subjects:
Adjuvants, Immunologic - therapeutic use
Administration, Intravesical
BCG Vaccine - therapeutic use
Humans
Immune Checkpoint Inhibitors - therapeutic use
Neoplasm Invasiveness
Neoplasm Recurrence, Local
Non-Muscle Invasive Bladder Neoplasms
Urinary Bladder Neoplasms - drug therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c357t-99b0a0057e70718c77b9da85b57435517655649f5b382a42d4a54429326a381a3
container_end_page 546
container_issue 6
container_start_page 545
container_title European urology
container_volume 84
creator Kulkarni, Girish S.
Wettstein, Marian S.
description
doi_str_mv 10.1016/j.eururo.2023.09.013
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2874267345</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030228382303138X</els_id><sourcerecordid>2874267345</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-99b0a0057e70718c77b9da85b57435517655649f5b382a42d4a54429326a381a3</originalsourceid><addsrcrecordid>eNp9kU2OEzEQhS0EYjIDN0DISzbd-KfddrNAIhGESAOzCIil5XZXiEO3Hex2pOy4wyw5AefgJpyEDhlYsirp6b16qvoQekJJSQmtn-9KyDHHUDLCeEmaklB-D82okryQoib30YxwwgqmuLpAlyntCCFcNPwhuuBSEVYrOkPf159ulnhNayJe4Hfh4PxnPIdj8B1eH9MIg7N4NQzZA15swX7ZB-dHvPJb17oxxCniw7iFaPZH7DyeG-v6Pie8MP0A4wjFMv_8EZ3_9e02-whpH3xyB8Dvw0kacrI9FM4fzB913puugzilvYX4CD3YmD7B47t5hT6-ef1h8ba4vlmuFq-uC8uFHIumaYkhREiQRFJlpWybzijRCllxIaishairZiNarpipWFcZUVWs4aw2XFHDr9Cz8959DF8zpFEPLlnoe-Mh5KSZkhWrJa_EZK3OVhtDShE2eh_dYOJRU6JPWPROn7HoExZNGj1hmWJP7xpyO0D3L_SXw2R4eTbAdOfBQdTJOpie0LkIdtRdcP9v-A0vzaOv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2874267345</pqid></control><display><type>article</type><title>SWOG S1605: Moving Beyond Systemic Immune Checkpoint Inhibitor Monotherapy in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer</title><source>ScienceDirect Journals</source><creator>Kulkarni, Girish S. ; Wettstein, Marian S.</creator><creatorcontrib>Kulkarni, Girish S. ; Wettstein, Marian S.</creatorcontrib><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2023.09.013</identifier><identifier>PMID: 37802681</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>Adjuvants, Immunologic - therapeutic use ; Administration, Intravesical ; BCG Vaccine - therapeutic use ; Humans ; Immune Checkpoint Inhibitors - therapeutic use ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local ; Non-Muscle Invasive Bladder Neoplasms ; Urinary Bladder Neoplasms - drug therapy</subject><ispartof>European urology, 2023-12, Vol.84 (6), p.545-546</ispartof><rights>2023 European Association of Urology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c357t-99b0a0057e70718c77b9da85b57435517655649f5b382a42d4a54429326a381a3</cites><orcidid>0000-0002-6929-6124</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37802681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kulkarni, Girish S.</creatorcontrib><creatorcontrib>Wettstein, Marian S.</creatorcontrib><title>SWOG S1605: Moving Beyond Systemic Immune Checkpoint Inhibitor Monotherapy in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer</title><title>European urology</title><addtitle>Eur Urol</addtitle><subject>Adjuvants, Immunologic - therapeutic use</subject><subject>Administration, Intravesical</subject><subject>BCG Vaccine - therapeutic use</subject><subject>Humans</subject><subject>Immune Checkpoint Inhibitors - therapeutic use</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasm Recurrence, Local</subject><subject>Non-Muscle Invasive Bladder Neoplasms</subject><subject>Urinary Bladder Neoplasms - drug therapy</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kU2OEzEQhS0EYjIDN0DISzbd-KfddrNAIhGESAOzCIil5XZXiEO3Hex2pOy4wyw5AefgJpyEDhlYsirp6b16qvoQekJJSQmtn-9KyDHHUDLCeEmaklB-D82okryQoib30YxwwgqmuLpAlyntCCFcNPwhuuBSEVYrOkPf159ulnhNayJe4Hfh4PxnPIdj8B1eH9MIg7N4NQzZA15swX7ZB-dHvPJb17oxxCniw7iFaPZH7DyeG-v6Pie8MP0A4wjFMv_8EZ3_9e02-whpH3xyB8Dvw0kacrI9FM4fzB913puugzilvYX4CD3YmD7B47t5hT6-ef1h8ba4vlmuFq-uC8uFHIumaYkhREiQRFJlpWybzijRCllxIaishairZiNarpipWFcZUVWs4aw2XFHDr9Cz8959DF8zpFEPLlnoe-Mh5KSZkhWrJa_EZK3OVhtDShE2eh_dYOJRU6JPWPROn7HoExZNGj1hmWJP7xpyO0D3L_SXw2R4eTbAdOfBQdTJOpie0LkIdtRdcP9v-A0vzaOv</recordid><startdate>202312</startdate><enddate>202312</enddate><creator>Kulkarni, Girish S.</creator><creator>Wettstein, Marian S.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6929-6124</orcidid></search><sort><creationdate>202312</creationdate><title>SWOG S1605: Moving Beyond Systemic Immune Checkpoint Inhibitor Monotherapy in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer</title><author>Kulkarni, Girish S. ; Wettstein, Marian S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-99b0a0057e70718c77b9da85b57435517655649f5b382a42d4a54429326a381a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adjuvants, Immunologic - therapeutic use</topic><topic>Administration, Intravesical</topic><topic>BCG Vaccine - therapeutic use</topic><topic>Humans</topic><topic>Immune Checkpoint Inhibitors - therapeutic use</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasm Recurrence, Local</topic><topic>Non-Muscle Invasive Bladder Neoplasms</topic><topic>Urinary Bladder Neoplasms - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kulkarni, Girish S.</creatorcontrib><creatorcontrib>Wettstein, Marian S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kulkarni, Girish S.</au><au>Wettstein, Marian S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SWOG S1605: Moving Beyond Systemic Immune Checkpoint Inhibitor Monotherapy in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2023-12</date><risdate>2023</risdate><volume>84</volume><issue>6</issue><spage>545</spage><epage>546</epage><pages>545-546</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>37802681</pmid><doi>10.1016/j.eururo.2023.09.013</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-6929-6124</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0302-2838
ispartof European urology, 2023-12, Vol.84 (6), p.545-546
issn 0302-2838
1873-7560
language eng
recordid cdi_proquest_miscellaneous_2874267345
source ScienceDirect Journals
subjects Adjuvants, Immunologic - therapeutic use
Administration, Intravesical
BCG Vaccine - therapeutic use
Humans
Immune Checkpoint Inhibitors - therapeutic use
Neoplasm Invasiveness
Neoplasm Recurrence, Local
Non-Muscle Invasive Bladder Neoplasms
Urinary Bladder Neoplasms - drug therapy
title SWOG S1605: Moving Beyond Systemic Immune Checkpoint Inhibitor Monotherapy in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A38%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SWOG%20S1605:%20Moving%20Beyond%20Systemic%20Immune%20Checkpoint%20Inhibitor%20Monotherapy%20in%20Bacillus%20Calmette-Gu%C3%A9rin%E2%80%93unresponsive%20Non%E2%80%93muscle-invasive%20Bladder%20Cancer&rft.jtitle=European%20urology&rft.au=Kulkarni,%20Girish%20S.&rft.date=2023-12&rft.volume=84&rft.issue=6&rft.spage=545&rft.epage=546&rft.pages=545-546&rft.issn=0302-2838&rft.eissn=1873-7560&rft_id=info:doi/10.1016/j.eururo.2023.09.013&rft_dat=%3Cproquest_cross%3E2874267345%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c357t-99b0a0057e70718c77b9da85b57435517655649f5b382a42d4a54429326a381a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2874267345&rft_id=info:pmid/37802681&rfr_iscdi=true